Novo Nordisk

Markets

Novo Nordisk Slips Amid Disappointing Wegovy Sales

Photo by News Øresund – Johan Wessman via CC BY 2.0

Novo Nordisk’s share price fell over 8% on Wednesday after the company reported lower-than-expected sales of Wegovy.

2 min read
Healthcare

Wegovy Finally Gains Regulatory Approval in China

Photo via Novo Nordisk

Novo Nordisk scored approval to sell its Wegovy weight loss drug in China. That’s a big win, but competitors will soon flood in.

2 min read
Healthcare

Hims & Hers Stock Jumps On New Discount Weight-Loss Drug Offering

Photo by Fin vs Fin via CC BY 2.0

A loophole lets the company create a back-door offering of a generic drug before the patents of Novo Nordisk and Eli Lilly expire.

2 min read
Regulation

FTC Challenges Hundreds of Pharma Patents

Photo by Chemist4U via CC BY-SA 2.0

The regulator sees some patents as ploys to keep companies from developing cheaper generic versions of 20 different brand-name drugs.

2 min read
Consumer

Weight-Loss Drugs Are Dragging Down Snack Makers’ Bottom Line

Photo by Chemist4U via CC BY-SA 2.0

A new survey finds evidence that “the drugs have a meaningful impact on consumer behavior and spending on groceries and restaurants.”

2 min read
Healthcare

Ozempic-like Drug Shows Signs of Mitigating Effects of Parkinson’s Disease

Photo by Anna Shvets via Pexels

A GLP-1 medication from French drugmaker Sanofi — similar to Ozempic — was found to slow Parkinson’s in a small mid-stage trial.

1 min read
Healthcare

Novo Nordisk May Have Found an Even Better Anti-Obesity Drug

Photo via Novo Nordisk

Novo Nordisk has announced a new drug in its pipeline performed much better than Wegovy in helping participants to lose weight.

2 min read